Guardant Health Receives European Approval Of Guardant360 CDx As Companion Diagnostic For AstraZeneca’s ETCAMAH
As Microsoft Adapted To AI Megatrend, Sales, Profits Surged. MSFT Leads 9 Joining IBD Best Stock Lists
Dow Jones Futures: S&P 500 Hits High As Astera, GE Vernova, Arista Lead Buys, But These Stocks Tumble
Guardant Health Announces Results From Its COSMOS-MEL01 Trial Shows 81% Sensitivity For Distant Recurrence, 100% Post-Treatment Facility
Dow Jones Futures Rise With Micron, Inflation Data Due; Yields Pressure Stocks But Bloom Energy Soars